ghk-cu immunogenicity antibody response Chemical structures of GHK and its copper and palmitoylated (Pal) Frontiers | Role of peptide–cell

GLOW Peptide Clinical Evidence Context Critical note No published human trial has evaluated BPC-157 + TB-500 + GHK-Cu as a combined stack

Another study with CuCl 2 treated Hep G2 cell line demonstrated that mitochondrial toxicity is an intermediate-level event associated with copper toxicity to Hep G2 cells while lysosomal damage is the early event and plasma damage a late feature associated with copper toxicity 34

I did just get a new script, and will likely now alternate old/new, injecting once a week

BPC-157 Research Peptide is often studied for fibroblast behaviour, especially in tendon and soft tissue models